The IPOX® Update 1/11/2025
IPO activity is picking up globally, with the US seeing filings from biotech firms like Maze and Metsera. Europe anticipates large listings from Stada and HBX Group, while Shein and Shawbrook consider London. In Asia, NTT plans a Singapore REIT IPO, and several Chinese firms eye Hong Kong, though CATL's faces US blacklisting concerns. LG CNS launched its IPO in South Korea, while K Bank canceled its attempt. Saudi Tabreed is planning a potential Riyadh IPO.
The IPOX® Update 1/4/2025
EG Group, a UK-based fuel station operator, is planning a U.S. IPO valued at over $16 billion. Ascentage Pharma seeks $100 million in a Nasdaq IPO for cancer treatments. Germany's IPO market anticipates growth in 2025 with major listings. Chery Auto aims for a $1 billion Hong Kong IPO, valuing it at $14 billion. Meanwhile, Hong Kong will see 8 IPOs raising $755 million by mid-January 2025, reflecting robust investor interest.
The IPOX® Update 12/21/2024
In recent IPO news, the US market sees Databricks potentially delaying its IPO post-funding, while FedEx explores options for its freight division. Shifting focus internationally, there's positive momentum as EV battery giant CATL considers a significant Hong Kong listing. Adding to the upbeat news, Greek multinational METLEN is advancing its multi-billion pound London IPO, showcasing confidence in European markets.
The IPOX® Update 12/14/2024
London's IPO market shows mixed signals with French streaming firm Canal+ planning a €5-6 billion listing, while facing challenges with Shein's delayed approval over supply chain concerns. In Asia, Orion Breweries prepares for a $200 million Tokyo listing, Foshan Haitian seeks a HK$1.5 billion Hong Kong dual listing, and Kioxia completed an $800 million IPO, though at a valuation significantly below its 2018 level.
The IPOX® Update 12/07/2024
Recent IPO announcements reflect strong global market activity across diverse sectors. Notable listings include Holcim's $30 billion North American spin-off, Seven & i's $6.6 billion 7-Eleven USA IPO, and ServiceTitan's $5.16 billion tech listing in the U.S. The MENA region sees healthcare and retail offerings from Almoosa Health and Nice One, while Asia-Pacific activity includes Kioxia's $727 million Tokyo listing and Mao Geping's $270 million Hong Kong debut.
Money Life with Chuck Jaffe: IPOX® CEO Josef Schuster on the IPO Market
IPOX® CEO Josef Schuster sat down with Chuck Jaffe on the Money Life with Chuck Jaffe podcast to discuss the state of the IPO market, its strong performance amid market highs, and the factors driving its momentum. Schuster highlighted the role of low interest rates, robust earnings, and the rise of sectors like AI and industrials in fueling IPO growth.
Reuters: IPOX® CEO Josef Schuster on ServiceTitan’s IPO
Josef Schuster, founder and CEO of IPOX Schuster LLC, was recently featured in Reuters, offering his perspective on the upcoming IPO of ServiceTitan, which aims for a valuation of up to $5.16 billion.
The IPOX® Update 11/30/2024
Global companies are preparing IPOs amid varied market conditions. In the U.S., ServiceTitan and CoreWeave plan significant offerings despite financial pressures. European firms like Apotea, Thyssenkrupp's Marine Systems, Odido, and Cirsa are set for listings. In Asia-Pacific, Insta360 and Mr DIY's Indonesian arm aim to go public. MENA's Talabat plans the UAE's largest IPO. Biotech firms Odyssey and Aktis proceed despite sector uncertainties, and Australia's Anteris files for a U.S. IPO.
The IPOX® Update 11/22/2024
Medline Industries plans a $5B U.S. IPO in 2025, potentially valuing the company at $50B. Pony AI seeks $260M in a U.S. IPO with Uber investing $10M. ServiceTitan files for Nasdaq listing, targeting SaaS growth. Canadian retailer Groupe Dynamite raises $300M. In Asia, Kioxia aims for $4.8B valuation, while Talabat targets $1.5B in Dubai. Australian DigiCo REIT launches a $1.8B IPO. UAE’s Pure Harvest eyes IPO by 2028.
Bloomberg: IPOX® CEO Josef Schuster on Canada’s IPO Market
IPOX® CEO Josef Schuster shared insights with Bloomberg on the renewed optimism in Canada’s IPO market, highlighted by Groupe Dynamite Inc.’s C$300 million debut. Schuster emphasized the IPOX® Canada Opportunities Index's adaptability, which has delivered a strong 36% return this year, outperforming the S&P/TSX Composite Index. The index reflects growing investor confidence and emerging opportunities as Canada’s equity markets show signs of recovery.